| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.73B | 23.13B | 23.48B | 23.07B | 16.98B | 10.44B |
| Gross Profit | 3.62B | 3.93B | 4.17B | 4.35B | 4.39B | 2.21B |
| EBITDA | 3.24B | 3.38B | 3.75B | 4.13B | 3.83B | 1.82B |
| Net Income | 1.37B | 1.46B | 1.19B | 1.33B | 1.30B | 347.66M |
Balance Sheet | ||||||
| Total Assets | 36.04B | 32.52B | 29.13B | 27.87B | 25.51B | 20.96B |
| Cash, Cash Equivalents and Short-Term Investments | 2.37B | 895.06M | 1.17B | 1.48B | 906.19M | 698.13M |
| Total Debt | 15.75B | 13.07B | 11.76B | 12.71B | 11.93B | 9.94B |
| Total Liabilities | 22.90B | 20.00B | 18.62B | 18.30B | 17.55B | 14.53B |
| Stockholders Equity | 9.55B | 8.96B | 7.69B | 6.89B | 5.69B | 4.53B |
Cash Flow | ||||||
| Free Cash Flow | -2.99B | -1.52B | 1.86B | 612.63M | -1.11B | -2.23B |
| Operating Cash Flow | 2.52B | 3.35B | 5.33B | 4.38B | 2.75B | 1.70B |
| Investing Cash Flow | -5.12B | -4.29B | -3.47B | -3.72B | -3.73B | -3.90B |
| Financing Cash Flow | 2.94B | 665.77M | -2.16B | -82.18M | 1.19B | 2.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$14.09B | 10.97 | 9.60% | 3.23% | 0.82% | 2.99% | |
71 Outperform | HK$11.24B | 7.77 | 11.27% | 3.66% | -0.34% | 64.10% | |
70 Outperform | HK$13.37B | 10.56 | 5.19% | 5.44% | -8.24% | -24.53% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$1.20B | 18.52 | 2.55% | 3.52% | -5.29% | -32.47% | |
59 Neutral | HK$1.24B | 7.69 | 7.36% | 2.20% | -8.51% | -68.34% | |
52 Neutral | HK$5.78B | 8.07 | 7.70% | ― | 9.20% | 213.87% |